(Reuters) - A trio of oral medicines from Abbott Laboratories Inc to treat hepatitis C produced unprecedented cure rates in patients who had previously failed to benefit from standard treatment, as well as very high cure rates for newly treated patients, Abbott said on Saturday.
via Reuters: Health News Read More Here..
No comments:
Post a Comment